Search

Search Constraints

You searched for: Author/Creator Maines, Francesca

Search Results

2. Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. (19th March 2019)

3. Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials. (February 2016)

4. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

5. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

6. Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program. (12th September 2018)

9. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients. (November 2015)

10. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients. (November 2015)